| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From INSERM U.148 and Department of Cell Biology*
and
Department of Pathology,
CHU de
Montpellier-Hôpital Lapeyronie, Montpellier, France
Fibulin-1, an extracellular matrix protein, is
secreted by human ovarian metastatic cancer cell lines under estrogen
stimulation. Fibulin-1 expression was quantified by
immunohistochemistry and computer-aided image analysis in 44 human
ovarian epithelial tumors and 14 normal ovaries. The fibulin-1 staining
intensity in proximal stroma, close to the surface of
epithelial cells and tumor cells, progressively increased from
normal ovaries to serous carcinomas. In all lesions, excluding
cystadenomas, fibulin-1 accumulation was higher in proximal
stroma than in distant stroma. In situ hybridization
demonstrated strong fibulin-1 gene expression in epithelial cells of
serous ovarian carcinomas and some cysts. The weak expression of
fibulin-1 RNA in some stromal cells of these tumors could not explain
the strong fibulin-1 protein accumulation in tumor stroma,
which was therefore mostly produced by tumor epithelial cells. In
carcinomas, fibulin-1 staining was not correlated with the
percentage of estrogen receptor-
(ER
)-stained nuclei but was
inversely correlated with the progesterone receptor. However,
in cystadenomas and borderline tumors, both fibulin-1 and ER
protein levels increased, in comparison with normal
ovaries, suggesting an effect of estrogens in the early steps
of tumorigenesis. This fibulin-1 overexpression, demonstrated
in vivo in ovarian carcinomas, might be a useful
indicator for predicting cancer risk and/or
aggressiveness.
This article has been cited by other articles:
![]() |
L. Xie, K. Palmsten, B. MacDonald, M. W. Kieran, S. Potenta, S. Vong, and R. Kalluri Basement Membrane Derived Fibulin-1 and Fibulin-5 Function as Angiogenesis Inhibitors and Suppress Tumor Growth Experimental Biology and Medicine, February 1, 2008; 233(2): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Yi, D. J. Smith, W. W. West, and M. A. Hollingsworth Loss of Fibulin-2 Expression Is Associated with Breast Cancer Progression Am. J. Pathol., May 1, 2007; 170(5): 1535 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiang, T. Sekine, H. Nakamura, S. Imajoh-Ohmi, H. Fukuda, K. Yudoh, K. Masuko-Hongo, K. Nishioka, and T. Kato Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J. Immunol., March 1, 2006; 176(5): 3196 - 3204. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kania, D. Corbeil, J. Fuchs, K. V. Tarasov, P. Blyszczuk, W. B. Huttner, K. R. Boheler, and A. M. Wobus Somatic Stem Cell Marker Prominin-1/CD133 Is Expressed in Embryonic Stem Cell-Derived Progenitors Stem Cells, June 1, 2005; 23(6): 791 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bardin, F. Moll, R. Margueron, C. Delfour, M. L. Chu, T. Maudelonde, V. Cavailles, and P. Pujol Transcriptional and Posttranscriptional Regulation of Fibulin-1 by Estrogens Leads to Differential Induction of Messenger Ribonucleic Acid Variants in Ovarian and Breast Cancer Cells Endocrinology, February 1, 2005; 146(2): 760 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Blackburn, E. E. Tarttelin, C. Y. Gregory-Evans, M. Moosajee, and K. Gregory-Evans Transcriptional Regulation and Expression of the Dominant Drusen Gene FBLN3 (EFEMP1) in Mammalian Retina Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4613 - 4621. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Schiemann, G. C. Blobe, D. E. Kalume, A. Pandey, and H. F. Lodish Context-specific Effects of Fibulin-5 (DANCE/EVEC) on Cell Proliferation, Motility, and Invasion. FIBULIN-5 IS INDUCED BY TRANSFORMING GROWTH FACTOR-beta AND AFFECTS PROTEIN KINASE CASCADES J. Biol. Chem., July 19, 2002; 277(30): 27367 - 27377. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Owens, R. A. Keri, and J. H. Nilson Ovulatory Surges of Human CG Prevent Hormone-Induced Granulosa Cell Tumor Formation Leading to the Identification of Tumor-Associated Changes in the Transcriptome Mol. Endocrinol., June 1, 2002; 16(6): 1230 - 1242. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |